The P/B of 2.13 sits well below the 84.61 figure shown in the ratio table, which appears to reflect a data-definition mismatch between price-to-book and a book-value series rather than a true multiple, so the valuation read relies on the market-quoted 2.13 figure. A P/E near 10 implies modest expectations for sustained ROE, consistent with the reported ROE range of 4.5% to 7.0%. Investors should monitor whether the sub-10 earnings multiple reflects a structural cap on returns or a temporary discount tied to claims timing.

Outside the 2026Q2 outlier, the combined ratio clustered between roughly 69% and 79%, which indicates an underwriting profit cushion that absorbs ordinary expense and loss variation. The expense ratio is unusually volatile, including a negative value in 2026Q2, which may point to reserve-related reclassification rather than operating efficiency. Warrants further investigation into whether the 2026Q3 loss ratio of 43.5% represents a durable improvement or a favorable timing effect.

Because investment income and yield fields are not disclosed in the supplied data, the split of ROE between underwriting profit and float income cannot be quantified. The low ROA of roughly 0.8% to 1.3% reflects a large asset base relative to earnings, which is typical of a life insurer carrying significant reserves. The gap between underwriting margin and ROE suggests returns may be constrained by capital retention or non-operating items that warrant further investigation.

Debt-to-equity has trended slightly lower over the period, which appears consistent with equity growth outpacing debt. Premium-to-surplus and RBC ratios are not provided, so underwriting leverage against the regulatory capital base cannot be confirmed from this dataset. Investors should monitor statutory capital disclosures before concluding that leverage is genuinely low.

GL's P/E of roughly 10 is in line with CNO's 12.5x, yet its ROE is far lower, which may indicate the market is pricing stability and niche distribution rather than return generation. Lincoln and Corebridge show higher ROE with lower multiples, which warrants further investigation into their reserve or capital-related drivers. The premium relative to some peers appears to rest on earnings durability rather than current return differentials.